Real-life EValuation Of high dose RosUvastatin in high risk patients after TitraTION - REVORUTION

Study identifier:NIS-CKR-CRE-2007/6

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An observational, non-interventional, multi-center study to evaluate efficacy and tolerability of high dose rosuvastatin in High Risk Patients after titration

Medical condition

Hypercholesterolemia

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1482

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 May 2007
Primary Completion Date: 01 Apr 2008
Study Completion Date: 01 Apr 2008

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria